CD56(bright) natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

Randomized trials have conclusively shown higher rates of chronic graft-versus-host disease with filgrastim-stimulated apheresis peripheral blood as a donor source than unstimulated bone marrow. The Canadian Blood and Marrow Transplant Group conducted a phase 3 study of adults who received either fi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Kariminia, Amina, Ivison, Sabine, Ng, Bernard, Rozmus, Jacob, Sung, Susanna, Varshney, Avani, Aljurf, Mahmoud, Lachance, Sylvie, Walker, Irwin, Toze, Cindy, Lipton, Jeff, Lee, Stephanie J., Szer, Jeff, Doocey, Richard, Lewis, Ian, Smith, Clayton, Chaudhri, Naeem, Levings, Megan K., Broady, Raewyn, Devins, Gerald, Szwajcer, David, Foley, Ronan, Mostafavi, Sara, Pavletic, Steven, Wall, Donna A., Couban, Stephan, Panzarella, Tony, Schultz, Kirk R.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5664398/
https://ncbi.nlm.nih.gov/pubmed/28935847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.170928
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados